Binding interactions of kistrin with platelet glycoprotein IIb‐IIIa: Analysis by site‐directed mutagenesis

Proteins: Structure, Function, and Bioinformatics

Volumn 15, Issue 3, 1993, Pages 312-321

  Dennis, Mark S ^a   Carter, Paul ^a   Lazarus, Robert A ^a  

^a GENENTECH INC   (United States)

Author keywords

GP IIb IIIa antagonist; platelet aggregation inhibitor; protein structure conformation; RGD sequence; snake venom disintegrin

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; GLYCINE; GLYCOPROTEIN; HYBRID PROTEIN; SNAKE VENOM;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS; THROMBOCYTE; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; BINDING SITES; CONSENSUS SEQUENCE; DNA, RECOMBINANT; ESCHERICHIA COLI; HUMAN; IN VITRO; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDES; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS;

EID: 0027465426     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.340150308     Document Type: Article

References (53)

1. Platelet glycoprotein IIb‐IIIa protein antagonists from snake venoms: Evidence for a family of platelet‐aggregation inhibitors
2. Disintegrins: A family of integrin inhibitory proteins from viper venoms
3. The platelet membrane glycoprotein IIb‐IIIa complex
4. Cellular adhesion: GP IIb‐IIIa as a prototypic adhesion receptor
5. Integrins and other cell adhesion molecules
6. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue‐type plasminogen activator in a canine preparation
7. Trigramin: A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb‐IIIa complex
8. Binding of the snake venom‐derived proteins applaggin and echistatin to the arginine‐glycine‐aspartic acid recognition site(s) on platelet glycoprotein IIb‐IIIa complex inibits receptor function
9. Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: Synthesis and biological activity of selected analogs
10. Echistatin: A potent platelet aggregation inhibitor from the venom of the viper Echis carinatus.
11. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb‐IIIa antagonist
12. Improved M13 phage cloning vectors and host strains: Nucleotide sequences of the M13mpl8 and pUC19 vectors
13. Different base/base mismatches are corrected with different efficiencies by the methyl‐directed DNA mismatch‐repair system of E. coli.
14. Synthesis of DNA via deoxynucleoside H‐phosphonate intermediates
15. Engineering subtilisin BPN′ for site‐specific proteolysis
16. DNA sequencing with chain‐terminating inhibitors
17. Importance of hydrogen‐bond formation in stabilizing the transition state of subtilisin
18. Mutagenesis facilitated by the removal or introduction of unique restriction sites
19. An algorithm for least squares estimation of non linear parameters
20. New perspectives in cell adhesion: RGD and intergins
21. Arginyl‐glycylaspartic acid (RGD): A cell adhesion motif
22. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets
23. Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion
24. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell‐binding domain of fibronectin
25. The effect of arg‐gly‐asp containing peptides on fibrinogen and von Willebrand factor binding to platelets
26. Arginine‐glycine‐aspartic adhesion receptors
27. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa
28. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells
29. Chemical cross‐linking of arginyl‐glycyl‐aspartic acid peptides to an adhesion receptor on platelets
30. The RGD binding domain of the vitronectin receptor
31. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb‐IIIa
32. Inhibition of platelet function with synthetic peptides designed to be high‐affinity antagonists of fibrinogen binding to platelets
33. High resolution analysis of functional determinants on human tissue‐type plasminogen activator
34. High‐resolution epitope mapping of hGH‐receptor interactions by alanine‐scanning mutagenesis
35. The binding site for C1q on IgG
36. High‐level expression in Escherichia coli of a chemically synthesized gene for [Leu‐28]echistatin
37. High‐level secretion of human growth hormone by Escherichia coli.
38. A synthetic IgG‐binding domain based on staphyloccal protein A
39. Site‐specific proteolysis of fusion proteins
40. Barbourin A GP IIb‐IIIa specific integrin antagonist from the venom of Sistrurus m. barbouri.
41. Influence of stereochemistry of the sequence RGD‐X on binding specificity in cell adhesion
42. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro
43. Cyclic RGD peptide analogues as antiplatelet antithrombotics
44. Development of novel, highly selective fibrinogen receptor antagonists as potentially useful antithrombotic agents
45. Decorsin, a potent glycoprotein IIb‐IIIa antagonist and platelet aggregation Inhibitor from the leech Macrobdella decora.
46. Ornatins: Potent glycoprotein IIb‐IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata.
47. Mambin: A potent glycoprotein IIb‐IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins
48. Three‐dimensional structure of echistatin, the smallest active RGD protein
49. A potential fusion peptide and an integrin ligand domain in a protein active in sperm‐egg fusion
50. The complete amino acid sequence of the high molecular mass hemorrhagic protein HR1B isolated from the venom of Trimeresurus flavoviridis.
51. A common precurosr for a putative hemorrhagic protein and rhodostomin, a platelet aggregation inhibitor of the venom of Calloselasma rhodostoma: Molecular cloning and sequence analysis